156 related articles for article (PubMed ID: 16511516)
81. Mouse Xenograft Model for Intraperitoneal Administration of NK Cell Immunotherapy for Ovarian Cancer.
Hermanson DL; Bendzick L; Kaufman DS
Methods Mol Biol; 2016; 1441():277-84. PubMed ID: 27177674
[TBL] [Abstract][Full Text] [Related]
82. Analysis of the colonization of unirradiated and irradiated SCID mice by human lymphoma and non-malignant lymphoid cells.
Zubair AC; Ali SA; Rees RC; Goepel JR; Winfield DA; Goyns MH
Leuk Lymphoma; 1996 Aug; 22(5-6):463-71. PubMed ID: 8882960
[TBL] [Abstract][Full Text] [Related]
83. Induction of human pluripotent stem cell-derived natural killer cells for immunotherapy under chemically defined conditions.
Matsubara H; Niwa A; Nakahata T; Saito MK
Biochem Biophys Res Commun; 2019 Jul; 515(1):1-8. PubMed ID: 30948156
[TBL] [Abstract][Full Text] [Related]
84. Emerging natural killer cell immunotherapies: large-scale ex vivo production of highly potent anticancer effectors.
Suck G; Koh MB
Hematol Oncol Stem Cell Ther; 2010; 3(3):135-42. PubMed ID: 20890071
[TBL] [Abstract][Full Text] [Related]
85. In Vivo (19)F-Magnetic Resonance Imaging of Adoptively Transferred NK Cells.
Somanchi SS; Kennis BA; Gopalakrishnan V; Lee DA; Bankson JA
Methods Mol Biol; 2016; 1441():317-32. PubMed ID: 27177678
[TBL] [Abstract][Full Text] [Related]
86. Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression.
Reissmann T; Hilgard P; Voegeli R; Zeller J
J Cancer Res Clin Oncol; 1989; 115(6):525-30. PubMed ID: 2606928
[TBL] [Abstract][Full Text] [Related]
87. Natural killer cells: from bench to cancer therapy.
Boyiadzis M; Foon KA
Expert Opin Biol Ther; 2006 Oct; 6(10):967-70. PubMed ID: 16989578
[TBL] [Abstract][Full Text] [Related]
88. MHC-unrestricted immune surveillance of leukemia.
Pawelec G
Cancer Biother; 1994; 9(3):265-88. PubMed ID: 7820187
[TBL] [Abstract][Full Text] [Related]
89. Isolation and (111)In-Oxine Labeling of Murine NK Cells for Assessment of Cell Trafficking in Orthotopic Lung Tumor Model.
Malviya G; Nayak T; Gerdes C; Dierckx RA; Signore A; de Vries EF
Mol Pharm; 2016 Apr; 13(4):1329-38. PubMed ID: 26962716
[TBL] [Abstract][Full Text] [Related]
90. [Comparison of Ex Vivo Expanded and Highly Purified NK Cell-Mediated Cytotoxicity Detected by 3 Different Staining Methods of Flow Cytometry].
Guo JQ; Han YP; Li F; Zhao Q; Jia Y; Jin BL; Zhang JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1691-1697. PubMed ID: 28024478
[TBL] [Abstract][Full Text] [Related]
91. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.
Woll PS; Grzywacz B; Tian X; Marcus RK; Knorr DA; Verneris MR; Kaufman DS
Blood; 2009 Jun; 113(24):6094-101. PubMed ID: 19365083
[TBL] [Abstract][Full Text] [Related]
92. Human neuroblastoma cell growth in xenogeneic hosts: comparison of T cell-deficient and NK-deficient hosts, and subcutaneous or intravenous injection routes.
Turner WJ; Chatten J; Lampson LA
J Neurooncol; 1990 Apr; 8(2):121-32. PubMed ID: 2358846
[TBL] [Abstract][Full Text] [Related]
93. Identification of Functional Fragments in gMYL6 and the Mechanism of Improving NK Cell-Mediated Cytotoxicity.
Ji Y; Cao R; Lv G; Jin Y; Chen J
Iran J Immunol; 2020 Dec; 17(4):292-302. PubMed ID: 33382386
[TBL] [Abstract][Full Text] [Related]
94. Large-Scale Culture and Genetic Modification of Human Natural Killer Cells for Cellular Therapy.
Lapteva N; Parihar R; Rollins LA; Gee AP; Rooney CM
Methods Mol Biol; 2016; 1441():195-202. PubMed ID: 27177667
[TBL] [Abstract][Full Text] [Related]
95. Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model.
Siegers GM; Felizardo TC; Mathieson AM; Kosaka Y; Wang XH; Medin JA; Keating A
PLoS One; 2011 Feb; 6(2):e16700. PubMed ID: 21304898
[TBL] [Abstract][Full Text] [Related]
96. Flow cytometry-based
Wong P; Wagner JA; Berrien-Elliott MM; Schappe T; Fehniger TA
STAR Protoc; 2021 Mar; 2(1):100262. PubMed ID: 33490978
[TBL] [Abstract][Full Text] [Related]
97. Combined NK Cell Therapy and Radiation Therapy Exhibit Long-Term Therapeutic and Antimetastatic Effects in a Human Triple Negative Breast Cancer Model.
Kim KW; Jeong JU; Lee KH; Uong TNT; Rhee JH; Ahn SJ; Kim SK; Cho D; Quang Nguyen HP; Pham CT; Yoon MS
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):115-125. PubMed ID: 31605787
[TBL] [Abstract][Full Text] [Related]
98. Role of natural effector cells in the prevention of radiation-induced leukemogenesis.
Datta SK
Biomed Pharmacother; 1996; 50(3-4):125-31. PubMed ID: 8881368
[TBL] [Abstract][Full Text] [Related]
99. Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice.
Kärre K; Klein GO; Kiessling R; Klein G; Roder JC
Nature; 1980 Apr; 284(5757):624-6. PubMed ID: 7366734
[No Abstract] [Full Text] [Related]
100. Development of humanized mouse with patient-derived xenografts for cancer immunotherapy studies: A comprehensive review.
Jin KT; Du WL; Lan HR; Liu YY; Mao CS; Du JL; Mou XZ
Cancer Sci; 2021 Jul; 112(7):2592-2606. PubMed ID: 33938090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
